Skip to main content

Table 2 Recurrence at each follow-up visit

From: Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?

 

Stage 2 recurrence

Stage 3 recurrence

End of treatment

(n = 18)

0

0

12 months

(n = 18)

3

0

24 months

(n = 18)

0

0

36 months

(n = 10)

0

1

48 months

(n = 9)

0

0